To the Editor: I wish to comment on Dr. Conti's recent review article on coronary arteriography.' Dr. Conti correctly points out the necessity for accurate assessment of the extent and severity of the occlusive process in the various segments of the coronary arterial tree; he emphasizes the value of scoring systems, computer coding of observer data and the troublesome fact of inter and intraobserver error.
sagittal plane for improved accuracy of cine coronary arteriography. Am J Roentgen Rad Ther Nuc Med 121: 565, 1974 5. Arani DT, Bunnell IL, Greene DG: Lordotic right posterior oblique projection of the left coronary artery. A special view for special anatomy. Circulation 52: 504, 1975 6. Aldridge HE, McLoughlin MJ, Taylor KW: Improved diagnosis in coronary cine arteriography with routine use of 1100 oblique views and cranial and caudal angulations. Am J Cardiol 36: 468, 1975 The author replies: To the Editor: I certainly agree with Dr. Bunnell that in some cases, in which coronary occlusive narrowings are not well visualized, it is necessary to use special angulated views in order to obtain better visualization of a lesion in the proximal portion of the left coronary artery. I would also extend this to narrowings in the proximal portion of the left anterior descending coronary artery and diagonal branches when they overlap. This capability is available in our laboratories but I think it is important to point out that hemi-axial or angulated views are not available in the majority of laboratories in this country or in the world. In the overwhelming majority of cases, it is not necessary to perform angiography in anything other than the usual RAO/LAO, left lateral, and frontal projections in order to properly define coronary anatomy. C. RICHARD CONTI, M.D.
University of Florida Gainesville, Florida 32610

Cyclical Reduction in Coronary Flow
To the Editor: Today I found an interesting paper concerning cyclical reduction in pressure and flow of partially constricted coronary arteries which was reported in Circulation (54: 365, 1975) by Dr. Folts et al.
In 1972, we also found the same phenomenon in dogs and reported on it several times.'-12 Our manuscript was submitted to Circulation in 1975, but it was not accepted.
In the paper by Dr. Folts et al., they suggested participation of cyclical formation of platelet aggregates at the constricted portion in this phenomenon. In our study, platelet aggregates were frequently found in the preparations in which the cyclical reduction did not occur and also in the preparations in which the cyclical reduction occurred. On the other hand, we frequently observed segmental or diffuse narrowing in the periphery of the constricted portion. Therefore, we consider that platelet aggregates found at the constricted portion did not play the major role in the cyclical reduction and that the platelet aggregates were formed after the excision of the coronary segments and were artifact and that cyclical vasospasm of the constricted coronary artery was responsible for this phenomenon. The chemical agents which could eliminate this cyclical reduction in pressure and flow were nitroglycerin (60 ,ug/kg), papaverine (500 Ag/kg), Mn++ (18 mg/kg), aspirin (50 mg/kg), sulpirin (100 mg/kg), nicotinic acid (20 mg/kg) and Sigma 75 (150 Atg/kg) which was discovered in Japan and is a potent coronary vasodilator but has a weak antiplatelet aggregation action.
On the other hand, indomethacin (20 ,ug/kg) eliminated transiently and augmented the cyclical reduction thereafter. Furthermore, dipyridamole, prostaglandin E, and adenosine in large doses could not affect this phenomenon. Aspirin, sulpirin and indomethacin suppress platelet aggregation through inhibition of production of prostaglandins. However, indomethacin augmented the cyclical reduction in a later phase. Nicotinic acid has no antiplatelet aggregation action, but it suppressed the cyclical reduction. In addition, dipyridamole and prostaglandin E, which have strong antiplatelet aggregation action were not effective while agents such as nitroglycerin and Sigma 75 which have weak antiplatelet aggregation action and have strong vasodilating action were effective. Therefore, it is more likely that coronary vasospasm is responsible for this phenomenon.
There are at least seven possible mechanisms for this phenomenon: 1) platelet aggregation, 2) vasospasm caused by the agents released from platelets, 3) vasospasm of the constricted portion by mechanical stimulus by the constrictor, 4) vasospasm in the segments peripheral to the constricted portion by cardiac motion, 5) vasospasm caused by ischemic products, 6) cyclical constriction of the coronary smooth muscles which was evoked by lowering perfusion pressure by constriction as in the case of portal vein and mesenteric artery, 7) vasospasm induced by cyclical excitation of the cardiac sympathetic or vagal nerves. Our studies could not support the first and seventh mechanisms. YASUMI UCHIDA, M.D. University of Tokyo Tokyo, Japan
